絞り込み

17065

広告

1369件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations.

Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib.

Chelidonine Selectively Inhibits the Growth of Gefitinib-resistant Non-small Cell Lung Cancer Cells through the EGFR-AMPK Pathway.

Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study.

Identification of a Triple Drug Combination That Is Synergistically Cytotoxic for Triple-Negative Breast Cancer Cells Using a Novel Combination Discovery Approach.

Glycine metabolomic changes induced by anticancer agents in A549 cells.

Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.

Variability of EGFR exon 20 insertions in 24,468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors.

Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies.

Irreversible kinase inhibitors targeting to cysteine residues and their applications in cancer therapy.

Preliminary Presentation of Metastatic Non-Small Cell Carcinoma of the Lung as Atraumatic Avulsion Fracture of the Lesser Trochanter.

Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors.

Multiple intraventricular metastases from lung adenocarcinoma with EGFR G719X mutation: a case report.

The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells.

Next-Generation Cancer-Specific Hybrid Theranostic Nanomaterials: MAGE-A3 NIR Persistent Luminescence Nanoparticles Conjugated to Afatinib for In Situ Suppression of Lung Adenocarcinoma Growth and Metastasis.

HOTAIR Competitively Binds MiRNA330 as a Molecular Sponge to Increase the Resistance of Gastric Cancer to Trastuzumab.

Long-term Survival With Afatinib in a Patient With Lung Adenocarcinoma Harboring Double Uncommon L861Q and G719X Mutations.

Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea.

Inflammatory changes in actinic keratoses associated with afatinib therapy.

Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります